NasdaqGM:OCULPharmaceuticals
Ocular Therapeutix (OCUL) Posts Wider Losses And Files Shelf Registration, Is It Still Undervalued?
Earnings and Shelf Registration Put Ocular Therapeutix in Focus
Ocular Therapeutix (OCUL) is back on investors’ radar after its latest quarterly earnings and a new shelf registration filing that opens the door to potential future common stock issuance.
See our latest analysis for Ocular Therapeutix.
The recent 4.82% 1 day share price return and 20.35% 7 day share price return suggest investors are reacting to Ocular Therapeutix’s earnings and shelf registration, although the share price...